Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity | MicrobiomeTrials

← Back to trials

NCT06979531

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2025-06-30Est. Completion: 2028-07

Enrollment target: 180 participants

Locations

Site Number - 1027, Covina, California, United States
Site Number - 1007, El Cajon, California, United States
Site Number - 1016, Menifee, California, United States
Site Number - 1029, Thousand Oaks, California, United States
Site Number - 1026, Upland, California, United States
Site Number - 1014, Fort Collins, Colorado, United States
Site Number - 1018, Hollywood, Florida, United States
Site Number - 1021, Jupiter, Florida, United States
Site Number - 1002, Miami, Florida, United States
Site Number - 1004, Tamarac, Florida, United States
Site Number - 1025, Tampa, Florida, United States
Site Number - 1012, Chicago, Illinois, United States
Site Number - 1033, Orland Park, Illinois, United States
Site Number - 1030, Lake Charles, Louisiana, United States
Site Number - 1028, New Orleans, Louisiana, United States
Site Number - 1032, Canton, New York, United States
Site Number - 1006, Mineola, New York, United States

Other microbiome trials you might be interested in

Investigation of Possible Sarcopenia and/or the Presence of Sarcopenia in Patients With Primary Sjögren's Syndrome and Its Effect on Functional StatusRecruiting

Primary Sjögren SyndromeSarcopenia

The aim of this study is to evaluate the frequency of probable sarcopenia and sarcopenia in patients with primary Sjögre…

Antalya, Turkey (Türkiye)Est. completion Jul 20, 2025

Phase 3 Study of Telitacicept in Active Primary Sjögren's DiseasePhase 3Recruiting

Primary Sjogren's Disease

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)

Chandler, United StatesEst. completion Dec 2028

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.